Lotus Pharmaceutical Co., Ltd. appointed Arni Hardarson as Representative of the Company's Institutional Director in place of Thor Kristjansson. Effective date of the new appointment is March 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
286.5 TWD | -1.72% | +2.69% | +5.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.33% | 2.39B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Change in Representative of the Company's Institutional Director